Loading
IP
Immune Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Fiorino Anthony S., was filed 23 May 2018.
Immune Pharmaceuticals Inc: what insiders have been doing
Every trade that managers of Immune Pharmaceuticals Inc disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Immune Pharmaceuticals Inc in twelve months, the latest record being from 4 February 2020.
Over the whole record (from 2016), the tally stands at 12 purchases and 1 sale.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
14
Thresholds
n/a
Buy Volume
€1M
12 ops. · all time
Sell Volume
€237
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-15.9M
Last declaration on 4 February 2020
Declarations14 total
75,000 shares@ US$0.0035100.0% of flowCommon StockSEC:0001608901-20-000002:0
25,000 shares@ US$0.239131.2% of flowCommon StockSEC:0001144204-18-030469:0
Canonical exit: 20 Aug 2018 (T+90)
50,000 shares@ US$0.25867.3% of flowCommon StockSEC:0001144204-18-029798:0
Canonical exit: 15 Aug 2018 (T+90)
76,503 shares@ US$0.18594.4% of flowCommon StockSEC:0001144204-17-000630:0
Canonical exit: 4 Apr 2017 (T+90)
161,377 shares@ US$0.18599.2% of flowCommon StockSEC:0001144204-16-140572:0
Canonical exit: 16 Mar 2017 (T+90)
185,473 shares@ US$0.040.9% of flowCommon StockSEC:0001144204-16-127730:0
868,902 shares@ US$0.4142.0% of flowCommon StockSEC:0001144204-16-120408:0
Canonical exit: 2 Nov 2016 (T+90)
666,667 shares@ US$0.4586.4% of flowCommon StockSEC:0001144204-16-116709:0
Canonical exit: 2 Nov 2016 (T+90)
777,778 shares@ US$0.45100.0% of flowCommon StockSEC:0001144204-16-116710:0
Canonical exit: 2 Nov 2016 (T+90)
937,500 shares@ US$0.3842.0% of flowCommon StockSEC:0001144204-16-116711:0
Canonical exit: 2 Nov 2016 (T+90)
42,000 shares@ US$0.591120.0% of flowCommon StockSEC:0001144204-16-077036:0
Canonical exit: 25 Apr 2016 (T+90)
44,200 shares@ US$0.565620.0% of flowCommon StockSEC:0001144204-16-076144:0
Canonical exit: 18 Apr 2016 (T+90)
39,400 shares@ US$0.624319.8% of flowCommon StockSEC:0001144204-16-075357:0
Canonical exit: 11 Apr 2016 (T+90)
62,000 shares@ US$0.80640.3% of flowCommon StockSEC:0001144204-16-074251:0
Canonical exit: 4 Apr 2016 (T+90)
14 of 14 declarations
About Immune Pharmaceuticals Inc
Immune Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on NASDAQ under the ticker IMNP.
